AU2018904241A0 - Novel compounds for the treatment of respiratory diseases - Google Patents

Novel compounds for the treatment of respiratory diseases

Info

Publication number
AU2018904241A0
AU2018904241A0 AU2018904241A AU2018904241A AU2018904241A0 AU 2018904241 A0 AU2018904241 A0 AU 2018904241A0 AU 2018904241 A AU2018904241 A AU 2018904241A AU 2018904241 A AU2018904241 A AU 2018904241A AU 2018904241 A0 AU2018904241 A0 AU 2018904241A0
Authority
AU
Australia
Prior art keywords
treatment
novel compounds
respiratory diseases
respiratory
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018904241A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Filing date
Publication date
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of AU2018904241A0 publication Critical patent/AU2018904241A0/en
Priority to AU2019374731A priority Critical patent/AU2019374731A1/en
Priority to PCT/AU2019/051225 priority patent/WO2020093098A1/en
Priority to EP19881903.9A priority patent/EP3877382A4/en
Priority to US17/291,707 priority patent/US20220002269A1/en
Priority to EP19882432.8A priority patent/EP3877383A4/en
Priority to AU2019376684A priority patent/AU2019376684A1/en
Priority to PCT/AU2019/051224 priority patent/WO2020093097A1/en
Priority to JP2021525325A priority patent/JP2022507117A/en
Priority to CN201980087269.9A priority patent/CN113260616A/en
Priority to US17/291,694 priority patent/US20220281846A1/en
Priority to JP2021525326A priority patent/JP2022507118A/en
Priority to CN201980087870.8A priority patent/CN113272298A/en
Abandoned legal-status Critical Current

Links

AU2018904241A 2018-11-07 2018-11-07 Novel compounds for the treatment of respiratory diseases Abandoned AU2018904241A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
CN201980087870.8A CN113272298A (en) 2018-11-07 2019-11-07 Compounds and compositions for the treatment of respiratory diseases
EP19882432.8A EP3877383A4 (en) 2018-11-07 2019-11-07 Compounds and compositions for the treatment of respiratory diseases
PCT/AU2019/051225 WO2020093098A1 (en) 2018-11-07 2019-11-07 Novel compounds for the treatment of respiratory diseases
EP19881903.9A EP3877382A4 (en) 2018-11-07 2019-11-07 Novel compounds for the treatment of respiratory diseases
US17/291,707 US20220002269A1 (en) 2018-11-07 2019-11-07 Novel compounds for the treatment of respiratory diseases
AU2019374731A AU2019374731A1 (en) 2018-11-07 2019-11-07 Compounds and compositions for the treatment of respiratory diseases
AU2019376684A AU2019376684A1 (en) 2018-11-07 2019-11-07 Novel compounds for the treatment of respiratory diseases
PCT/AU2019/051224 WO2020093097A1 (en) 2018-11-07 2019-11-07 Compounds and compositions for the treatment of respiratory diseases
JP2021525325A JP2022507117A (en) 2018-11-07 2019-11-07 A novel compound for the treatment of respiratory diseases
CN201980087269.9A CN113260616A (en) 2018-11-07 2019-11-07 Novel compounds for the treatment of respiratory diseases
US17/291,694 US20220281846A1 (en) 2018-11-07 2019-11-07 Compounds and compositions for the treatment of respiratory diseases
JP2021525326A JP2022507118A (en) 2018-11-07 2019-11-07 Compounds and compositions for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
AU2018904241A0 true AU2018904241A0 (en) 2018-11-22

Family

ID=

Similar Documents

Publication Publication Date Title
EP3781564A4 (en) Compounds for the treatment of cancer
EP3621973A4 (en) Compounds for the prevention and treatment of diseases and the use thereof
EP3986392A4 (en) Compounds for treatment of pd-l1 diseases
EP3790867A4 (en) Kdm1a inhibitors for the treatment of disease
EP3790563A4 (en) Compositions for the treatment of skin conditions
EP3784260A4 (en) Compositions for the treatment of skin conditions
EP3448851B8 (en) Di-substituted pyrazole compounds for the treatment of diseases
SG11202006374VA (en) Treatment of demyelinating diseases
EP3600286A4 (en) Compounds and methods for the treatment of parasitic diseases
EP4045037A4 (en) Heteroaryl-biphenyl amines for the treatment of pd-l1 diseases
IL279397A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
EP3805216A4 (en) Compounds for treatment or prevention of liver diseases
EP3593803A4 (en) Compounds for the treatment of diseases caused by oxalate accumulation
SG11202108636SA (en) Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer
EP3911313A4 (en) Thienyl-aniline compounds for treatment of dermal disorders
EP3619204A4 (en) Compounds for the treatment of respiratory diseases
EP3846821A4 (en) Combination therapy for the treatment of liver disease
EP3813872A4 (en) Compositions for the treatment of skin conditions
EP3877382A4 (en) Novel compounds for the treatment of respiratory diseases
EP3829560A4 (en) Compounds for the treatment of neurological or mitochondrial diseases
EP3883552A4 (en) Cyanoaryl-aniline compounds for treatment of dermal disorders
EP3883567A4 (en) Naphthyridinone-aniline compounds for treatment of dermal disorders
EP3761982A4 (en) Treatment of demyelinating diseases
EP3866601A4 (en) Organosilanes for the treatment of infections
EP3820477A4 (en) Compounds, compositions, and methods for the treatment of disease